L. Liu et al. / Tetrahedron: Asymmetry 24 (2013) 533–542
541
Analytical thin layer chromatography (TLC) was performed using
Acknowledgments
Merck 60 F254 precoated silica gel plate. Subsequent to elution,
the plates were visualized using UV radiation (254 nm) on a
Spectroline Model ENF-24061/F 254 nm.
We are grateful for the financial support from the National Nat-
ural Science Foundation of China (21142009) and Tianjin Natural
Science Foundation of China (12JCQNJC03500) for this work.
4.2. Procedure for the preparation of the organocatalyst
References
To a stirred solution of N-Boc-L-proline (1.25 g, 5.81 mmol) in
1. (a) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615–1621; (b) Eder, U.;
Sauer, R.; Wiechert, R. Angew. Chem., Int. Ed. 1971, 10, 496–497; (c) List, B.;
Lerner, R. A.; Barbas, C. F., III J. Am. Chem. Soc. 2000, 122, 2395–2396; (d)
Sakthivel, K.; Notz, W.; Bui, T.; Barbas, C. F., III J. Am. Chem. Soc. 2001, 123, 5260–
5267.
CH2Cl2, Et3N (1.2 mL, 8.71 mmol) was added slowly at 0 °C. After
the solution was stirred for 10 min, isobutyl chloroformate
(875
at 0 °C. After the solution was stirred for an additional 20 min at
0 °C, Et3N (90 L, 6.67 mmol) and -valine methyl ester hydrochlo-
lL, 6.67 mmol) was added dropwise to the reaction mixture
2. (a) Dondoni, A.; Massi, A. Angew. Chem., Int. Ed. 2008, 47, 4638–4660; (b) Raj, M.;
Parashari, G. S.; Singha, V. K. Adv. Synth. Catal. 2009, 351, 1284–1288; (c)
Calderon, F.; Fernandez, R.; Sanchez, F.; Fernandez-Mayoralas, A. Adv. Synth.
Catal. 2005, 347, 1395–1403; (d) Tzeng, Z.-H.; Chen, H.-Y.; Reddy, R. J.; Huang,
C.-T.; Chen, K.-M. Tetrahedron 2009, 65, 2879–2888; (e) Da, C.-S.; Che, L.-P.; Guo,
Q.-P.; Wu, F.-C.; Ma, X.; Jia, Y.-N. J. Org. Chem. 2009, 74, 2541–2546; (f)
Paradowska, J.; Rogozinska, M.; Mlynarski, J. Tetrahedron Lett. 2009, 50, 1639–
1641; (g) Yan, J.-C.; Wang, L. Synthesis 2008, 2065–2072; (h) Guillena, G.; Hita,
M. D. C.; Najera, C.; Viozquez, S. F. Tetrahedron: Asymmetry 2007, 18, 2300–2304;
(i) Xu, X.-Y.; Wang, Y.-Z.; Gong, L.-Z. Org. Lett. 2007, 9, 4247–4249; (j) Cordova,
A.; Zou, W.-B.; Dziedzic, P.; Ibrahem, I.; Reyes, E.; Xu, Y.-M. Chem. Eur. J. 2006, 12,
5383–5397; (k) Hayashi, Y.; Sumiya, T.; Takahashi, J.; Gotoh, H.; Urushima, T.;
Shoji, M. Angew. Chem. 2006, 118, 972. Angew. Chem., Int. Ed. 2006, 45, 958–961;
(l) Dziedzic, P.; Zou, W.-B.; Hafren, J.; Cordova, A. Org. Biomol. Chem. 2006, 4, 38–
40; (m) Samanta, S.; Liu, J.-Y.; Dodda, R.; Zhao, C.-G. Org. Lett. 2005, 7, 5321–
5323; (n) Zou, W.-B.; Ibrahem, I.; Dziedzic, P.; Sunden, H.; Cordova, A. Chem.
Commun. 2005, 39, 4946–4948; (o) Cordova, A.; Notz, W.; Barbas, C. F., III Chem.
Commun. 2002, 24, 3024–3025; (p) Notz, W.; List, B. J. Am. Chem. Soc. 2000, 122,
7386–7387; (q) Gruttadauria, M.; Giacalone, F.; Noto, R. Catalytic Methods
Asymmetric Synth. 2011, 83–175; (r) Kano, T.; Song, S.; Kubota, Y. Angew. Chem.,
Int. Ed. 2012, 51, 1191–1194; (s) Giacalone, F.; Gruttadauria, M.; Agrigento, P.
Chem. Soc. Rev. 2012, 41, 2406–2447; (t) Rambo, R. S.; Schneider, R. S.
Tetrahedron: Asymmetry 2010, 21, 2254–2257.
3. (a) Kobayashi, J.; Ishibashi, M. Chem. Rev. 1993, 93, 1753–1769; (b) Chakraborty,
T.; Das, S. Curr. Med. Chem.: Anti Cancer Agents 2001, 1, 131–149; (c) Tsuda, M.;
Kubota, T.; Sakuma, Y.; Kobayashi, J. Chem. Pharm. Bull. 2001, 49, 1366–1367; (d)
Kobayashi, J.; Shimbo, K.; Kubota, T.; Tsuda, M. Pure Appl. Chem. 2003, 75, 337–
342; (e) Kobayashi, J.; Tsuda, M. Nat. Prod. Rep. 2004, 21, 77–93; (f) Suri, J. T.;
Ramachary, D. B.; Barbas, C. F., III Org. Lett. 2005, 7, 1383–1385; (g) Font, D.;
Jimeno, C.; Pericas, M. A. Org. Lett. 2006, 8, 4653–4655; (h) Kumar, A.; Singh, S.;
Kumar, V. Org. Biomol. Chem. 2011, 9, 2731–2742; (i) Sarkar, D.; Harman, K.;
Ghosh, S. Tetrahedron: Asymmetry 2011, 22, 1051; (j) Liu, C.; Dou, X.; Lu, Y. Org.
Lett. 2011, 13, 5248–5251; (k) Wu, X.; Ma, Z.; Ye, Z. Adv. Synth. Catal. 2009, 351,
158–162; (l) Paradowska, J. Tetrahedron Lett. 2009, 50, 1639–1641.
4. (a) List, B.; Pojarliev, P.; Castello, C. Org. Lett. 2001, 3, 573–575; (b) Benaglia, M.;
Cenlentano, G.; Cozzi, F. Adv. Synth. Catal. 2001, 343, 171–173; (c) Maggiotti, V.;
Resmini, M.; Gouverneur, V. Angew. Chem. 2002, 114, 1054–1056. Angew. Chem.,
Int. Ed. 2002, 41, 1012–1016; (d) Liu, H.; Peng, L.; Zhang, T.; Li, Y. New J. Chem.
2003, 27, 1159–1160; (e) Magiotti, V.; Bahmanyar, S.; Reiter, M.; Resmini, M.;
Houk, K. N.; Gouverneur, V. Tetrahedron 2004, 60, 619–632; (f) Pan, Q.; Zou, B.;
Wang, Y.; Ma, D. Org. Lett. 2004, 6, 1009–1012; (g) Storer, R. I.; MacMillan, D. W.
C. Tetrahedron 2004, 60, 7705–7714; (h) Guillena, G.; Hita, M. C. M.; Najera, C.
Tetrahedron: Asymmetry 2006, 17, 1027–1031; (i) Gu, Q.; Wang, X. F.; Wang, L.;
Wu, X.-Y.; Zhou, Q.-L. Tetrahedron: Asymmetry 2006, 17, 1537–1540; (j)
Calderon, F.; Doyaguez, E. G.; Fernandez-Mayoralas, A. J. Org. Chem. 2006, 71,
6258–6261; (k) Ramasastry, S. S. V.; Zhang, H.; Tanaka, F.; Barbas, C. F., III J. Am.
Chem. Soc. 2007, 129, 288–289; (l) Wu, X.-Y.; Jiang, Z.-Q.; Shen, H.-M.; Lu, Y.-X.
Adv. Synth. Catal. 2007, 349, 812–816; (m) Guillena, G.; Hita, M. del C. M.; Najera,
C. Tetrahedron: Asymmetry 2007, 18, 1272–1277; (n) Luo, S.-Z.; Xu, H.; Zhang, L.;
Li, J.-Y.; Cheng, J.-P. Org. Lett. 2008, 10, 653–656; (o) Guillena, G.; Hita, M. D. C.;
Najera, C.; Viozquez, S. F. J. Org. Chem. 2008, 73, 5933–5943; (p) Angelici, G.;
Falgiani, A.; Luppi, G.; Kaptein, B.; Broxterman, Q. B.; Tomasini, C. Synth.
Commun. 2008, 38, 1137–1146; (q) Ramasastry, S. S. V.; Albertshofer, K.; Utsumi,
N.; Tanaka, F.; Barbas, C. F., III; Kucherenko, A. S.; Siyutkin, D. E.; Muraviev, V. O.;
Struchkova, M. I.; Zlotin, S. G. Mendeleev Commun. 2007, 17, 277–278; (r) Wu, X.-
Y.; Ma, Z.-X.; Ye, Z.-Q.; Qian, S.; Zhao, G. Adv. Synth. Catal. 2009, 351, 158–162; (s)
Tang, Z.; Jiang, F.; Cui, X.; Gong, L.-Z.; Mi, A.-Q.; Jiang, Y.-Z.; Wu, Y.-D. Proc. Natl.
Acad. Sci. U.S.A. 2004, 101, 5755–5760; (t) Notz, W.; Tanaka, F. J.; Barbas, C. F., III
Acc. Chem. Res. 2004, 37, 580–591; (u) Wennemers, H. Chem. Commun. 2011, 47,
12036–12041; (v) Nugent, T. C.; Umar, M. N.; Bibi, A. Org. Biomol. Chem. 2010, 8,
4085–4089; (w) Ban-Caballero, A.; Guillena, G.; Najera, C. Green Chem. 2012, 12,
1599–1606; (x) Li, J.; Luo, S.; Cheng, J. P. J. Org. Chem. 2009, 74, 1747–1750.
5. Tang, Z.; Yang, Z.-H.; Cun, L.-F.; Mi, A.-Q.; Jiang, Y.-Z.; Gong, L.-Z. Org. Lett. 2004,
6, 2285–2287.
l
L
ride (1.10 g, 6.67 mmol) were added to the reaction mixture. The
reaction mixture was then warmed up to room temperature. After
3 h, TLC analysis indicated complete consumption of the starting
material. The reaction was quenched by the addition of 1 M HCl
and diluted with CH2Cl2.The organic phase was washed with
H2O, brine and dried over Na2SO4, filtered, and then concentrated
under reduced pressure. Purification was accomplished by
recrystallization (EtOAc/n-hexane) to give compound (S)-tert-
butyl-2-((S)-1-methoxy-3-methyl-1-oxo-butan-2-ylcarbamoyl)pyr-
rolidine-1-carboxylate (1.66 g, yield 87%, white crystal). Mp
68–70 °C; ½a 2D0
ꢂ
¼ ꢁ102:0 (c 1.0, EtOH); 1H NMR (400 MHz, CDCl3):
d 0.91 (d, 3H, J = 7.0 Hz), 0.94 (d, 3H, J = 6.9 Hz), 1.46 (s, 9H),
1.71–1.80 (m, 3H), 1.85–1.99 (m, 2H), 2.10–2.25 (m, 1H),
2.37–3.47 (m, 2H), 3.72 (s, 3H), 4.36–4.44 (m, 2H).
A mixture of the above compound (657 mg, 2 mmol) and
Lawesson’s reagent (410 mg, 1 mmol) in dry THF was stirred for
2 h at room temperature and then refluxed for 0.5 h under argon
atmosphere. After removal of the solvent under reduced pressure,
the resulting residue was purified by flash chromatography
(hexane/EtOAc) to afford compound (S)-tert-butyl 2-((S)-1-meth-
oxy-3-methyl-1-oxobutan-2-ylcarbamothioyl)pyrrolidine-1-car-
boxylate (448 mg, yield 65%, white solid). 1H NMR (400 MHz,
CDCl3): d 0.92–0.99 (m, 6H), 1.44 (s, 9H), 1.72–1.75 (m, 2H),
1.86–1.87 (m, 2H), 2.01 (br s, 1H), 2.29–2.34 (m, 1H), 3.45–3.50
(m, 2H), 3.75 (s, 3H), 4.68–4.70 (m, 1H), 5.06–5.08 (m, 1H).
The above compound (482 mg, 1.4 mmol) was dissolved in dry
CH2Cl2 (2.8 mL) and then TFA (1.4 mL) and Et3SiH (0.55 mL) were
added. After 2 h, the solvent was removed, diluted with CH2Cl2
and washed with saturated NaHCO3, dried over Na2SO4, filtered,
and then concentrated under reduced pressure to give catalyst
1b (266 mg, yield 78%, yellow oil). ½a D20
¼ ꢁ53:6 (c 1.0, CH2Cl2);
ꢂ
1H NMR (400 MHz, CDCl3): d 0.94–1.00 (dd, 6H, J = 6.9, 10.9 Hz),
1.65–1.78 (m, 2H), 2.00–2.04 (m, 2H), 2.35–2.38 (m, 2H), 3.01–
3.09 (m, 2H), 3.75 (s, 3H), 4.21–4.26 (dd, 1H, J = 3.8, 9.0 Hz),
5.12–5.14 (m, 1H), 10.36 (br s, 1H); 13C NMR (100 MHz, CDCl3): d
205.9, 171.2, 67.9, 61.8, 52.3, 47.5, 34.7, 31.2, 26.1, 18.9, 18.5;
HR-MS (ESI) calcd for
245.1322.
C11H20N2O2S (M+1), 245.1318 found:
4.3. Typical procedure for the aldol reaction of the aldehyde
with hydroxyacetone catalyzed by an organocatalyst
To a mixture of organocatalyst 1b (0.05 mmol) and additives
(0.05 mmol) in DMSO (0.2 mL), hydroxyacetone (111 mg,
1.5 mmol, 6 equiv) was added. After the corresponding mixture
was stirred for 5 min, the aldehyde (0.25 mmol) was added at
0 °C. After 2–4 days, TLC analysis indicated the complete consump-
tion of the starting material, after which the reaction mixture was
quenched with a saturated NH4Cl solution, extracted with EtOAc
and dried over Na2SO4. The crude product was purified by flash sil-
ica gel chromatography (hexane/EtOAc) to afford the aldol
products.
6. (a) Chen, X.-H.; Luo, S.-W.; Tang, Z.; Cun, L.-F.; Mi, A.-Q.; Jiang, Y.-Z.; Gong, L.-Z.
Chem. Eur. J. 2007, 13, 689–701; (b) Wu, F.-C.; Da, C.-S.; Du, Z.-X.; Guo, Q.-P.; Li,
W.-P.; Yi, L.; Jia, Y.-N.; Ma, X. J. Org. Chem. 2009, 74, 4812–4818.
7. (a) Wang, B.; Chen, G. H.; Liu, L. Y.; Chang, W. X.; Li, J. Adv. Synth. Catal. 2009, 351,
2441–2448; (b) Wang, B.; Liu, X. W.; Liu, L. Y.; Chang, W. X.; Li, J. Eur. J. Org.
Chem. 2010, 5951–5954.